Combination of TLR1/2 and TLR3 ligands enhances CD4⁺ T cell longevity and antibody responses by modulating type i IFN production

Immunology and Microbiology

• TLR3 75%
• TLR 1 75%
• T-Helper Cell 75%
• Interferon Type I 50%
• Vaccine Efficacy 50%
• Antigen 50%
• Proinflammatory Cytokine 25%
• Signal Transduction 25%
• Monospecific Antibody 25%
• Antibody Response 25%
• Antigen Specificity 25%
• Interferon Production 25%
• Humoral Immunity 25%
• Adjuvant 25%
• IRF3 25%
• Longevity 25%
• Follicular B Helper T Cells 25%
• Contrast 25%
• Regulatory Mechanism 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Ligand 100%
• Antigen 75%
• Toll Like Receptor 3 75%
• Toll Like Receptor 1 75%
• Cytokine 50%
• Antibody 50%
• Vaccine 50%
• Toll Like Receptor 50%
• Interferon Type I 50%
• Interferon 25%
• Adjuvant 25%
• Interferon Regulatory Factor 3 25%

Biochemistry, Genetics and Molecular Biology

• TLR3 75%
• Cytokine 50%
• Interferon Type I 50%
• Signal Transduction 25%
• Longevity 25%
• IRF3 25%
• Proinflammatory Cytokine 25%
• Antigen Specificity 25%
• Humoral Immunity 25%
• Antibody Response 25%
• Interferon Production 25%
• Contrast 25%
• Regulatory Mechanism 25%